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Background: In China, high prevalence of HBV and HCV parallels with the growing epidemic of syphilis and HIV in
the general population poses a great threat to blood safety. This study investigated the prevalence of serologic
markers for transfusion transmissible infections (TTIs) among four Chinese blood centers.
Methods: We examined whole blood donations collected from January 2000 through December 2010 at four
Chinese blood centers. Post-donation testing of TTIs (HIV, HBV, HCV and syphilis) were conducted using two
different enzyme-linked immunosorbent assay kits for each seromarker. The prevalence of serologic markers for TTIs
(%) was calculated and additional analysis was conducted to examine donor characteristics associated with positive
TTIs serology.
Results: Of the 4,366,283 donations, 60% were from first-time donors and 40% were from repeated donors. The
overall prevalence of HIV, HBsAg, HCV and syphilis was 0.08%, 0.86%, 0.51% and 0.47%, respectively. The prevalence
profile of TTIs varied among different blood centers and appeared at relatively high levels. Overall, the prevalence
of HBsAg and HCV demonstrated a decline trend among four blood centers, while the prevalence of HIV and
syphilis displayed three different trends: constantly steady, continually increasing and declining among different
centers.
Conclusions: This study reflects the risk of TTIs has been greatly reduced in China, but blood transfusion remains
an ongoing risk factor for the spread of blood-borne infections, and further work and improvements are needed to
strengthen both safety and availability of blood in China.
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Human blood is a major source of diverse medical pro-
ducts that are used for the prevention and treatment of
various life-threatening diseases. However, blood trans-
fusion has been subjected to contamination with differ-
ent human pathogens that may induce a wide variety of* Correspondence: lwpzhr@sina.com
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reproduction in any medium, provided the orrisk, especially transfusion-transmissible infections (TTIs)
such as HIV, HBV, HCV and syphilis. Over the past three
decades, the risk of TTIs has been dramatically reduced
by the introduction of routine donor laboratory screen-
ing of blood-borne pathogens [1,2]. In the EU and the
United States, due to continuous implementation and
improvement of more sensitive serologic methods and
nucleic acid amplification test (NAT), the residual risk of
viral transmission decreased in 2000 to less than 1:
250,000 for hepatitis C virus (HCV) and 1: 1.3 M for HIV
[1,3]. By contrast, TTIs still pose a great threat to blood
safety.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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at blood centers/banks. There are more than 452 blood
centers/banks at three levels: provincial (32), regional
(321), and county (99). Local government health offices
oversee the operation of Chinese blood centers/banks.
Since the Blood Donation Law came into effect in 1998,
many changes have been made in the field of blood
banking. Blood collection has been successfully shifted
from paid and employer-organized donations to volun-
tary donation. As a result, voluntary donations have
increased from 5.5% (50,000 donations) in 1998 to 99%
(12,320,000 donations) in 2011. Overall blood collection
has increased from fewer than 1000 tons to 4164 tons.
Although blood collection volume has increased dramat-
ically, the increase in the blood supply has not kept pace
with the increasing clinical demand for blood[4]. The
blood donation rate is only 9% of the whole population,
much lower than that the WHO demands: 10–30%. In
the area of donor screening in China, a standardized na-
tional donor screening policy has been implemented. It
requires that (1) all potential donors undergo a screen-
ing process to meet the donor eligibility requirements
before donating; (2) after passing the predonation
screening process, blood units will be collected and
undergo two rounds of routine serological testing for
HBsAg, ALT, hepatitis C virus (HCV) antibodies, hu-
man immunodeficiency virus (HIV) antibodies, and syph-
ilis antibodies by two different reagents which are
imported as well as domestic testing kits approved and li-
censed by the Chinese State Food andDrug Administration.
Although the prevalence of these diseases in a general
population of selective participants has been addressed,
there are limited epidemiological data on TTIs in blood
donors in China. As the infection increasingly spreads
further into the general population and the number of
HIV cases keeps growing rapidly in China, the risk of
transfusion-transmitted HIV poses a conspicuous threat
to blood safety [5,6]. Previous studies have demonstrated
that the prevalence of HBV and HCV is quite high in
China, approximately 9.8% of the Chinese population
tested positive for hepatitis B virus surface antigen
(HBsAg) before the introduction of the HBV vaccination
program in 1992. Fortunately, the HBsAg carrier rate
decreased to 7.2% among the general population in 2006
[7,8]. The nationwide prevalence of HCV infection was
estimated to be 3.2% in 1992. The regional data indi-
cated that the prevalence of HCV rose to 12.87% of
blood donors before 1998 and dramatically decreased to
1.71% later on [9]. However, epidemiological studies of
HCV are limited compared to those of HBV [10,11].
During the past 20 years, syphilis has made resurgence
in China. In 1993, the reported overall rate of cases of
syphilis was 0.2 cases per 100,000 persons, whereas pri-
mary and secondary syphilis alone represented 5.7 casesper 100,000 persons in 2005. Furthermore, the rate of
congenital syphilis increased sharply from 1991 to 2005,
from 0.01 cases per 100,000 live births to 19.68 cases per
100,000 live births, with an average yearly rise of 71.9%
[12]. One study demonstrated that there was a signifi-
cant growth in syphilis serologic markers among first-
time donors from 2008 to 2010 [13]. Although a number
of studies have monitored the epidemiology of HIV,
HBV, HCV and syphilis in China’s general population
and its high-risk population, data revealing the epidemi-
ology from blood donor groups are significantly limited.
In the present study, we assessed the prevalence of TTIs
among voluntary blood donors in four blood centers
from 2000 to 2010. A retrospective review of donors’ rec-
ord covering the period was carried out. All samples were
screened for HIV, HBsAg, HCV, syphilis. The safety of
the blood supply can be estimated by monitoring the
prevalence of these pathogens in blood donations, and a
reliable index for policy making can be produced.
Methods
Participants and principle of the study
The Institute of Blood Transfusion at Chengdu (China),
collaborated with four Chinese regional blood centers in
Guangzhou, Nanjing, Liaoning and Yancheng. These
four centers were the participants of this study. Figure 1
shows the geographic distribution of the four blood cen-
ters and the Institute of Blood Transfusion. The four
blood centers were selected for their geographic and
economic level: Guangzhou, located in Southeast China,
represents an economically developed region; Liaoning,
located in Northeast China, represents an economically
developing region; Nanjing and Yancheng, located in
mid-East China, also represent an economically devel-
oped region. The first three are provincial capital city
level blood centers and Yancheng is a blood center serv-
ing second-tier (smaller) cities. The study population
consists of all blood donors who donated at one of the
four participating blood centers or at one of their mobile
blood collection vehicles between January 1, 2000 and
December 31, 2010. All blood donations were collected
and screened for the serological makers for HIV, HBV,
HCV and syphilis, and the seroprevalence of these
pathogens in blood donors was evaluated to investigate
the blood safety in China.
Pre-donation screening
Due to the high prevalence of HBV and HCV in China’s
general population and exclude potential window period
infection, all blood donors were required to pass a rou-
tine pre-donation screening process, including a health
history questionnaire screening, pre-donation rapid
testing, and a brief physical examination. The health his-
tory questionnaire has minor variations across the
Figure 1 Locations of study sites in China. IBT = Institute of Blood Transfusion.
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the required screening fields mandated by the Chinese
Ministry of Health. Pre-donation rapid testing procedures
vary across blood centers, but all tested for hepatitis B
virus surface antigen (HBsAg), ABO blood type, and
hemoglobin. Alanine aminotransferase (ALT) screening
was also being performed at selected centers. Liaoning
blood center began HBsAg predonation rapid testing in
May 2001; all the other blood centers began this test be-
fore 2000. Risk behavior detected in the health history
questionnaire, an abnormal result in pre-donation rapid
testing or failure to pass the physical examination
(e.g., body weight lower than 45 kg) resulted in the
donor’s deferral. Donors who meet the donor eligibility
requirements proceeded to donate blood.
TTIs testing
After a donor passed the pre-donation screening, a
blood unit was collected. All donor samples underwent
two rounds of enzyme immunoassay (EIA) testing withTable 1 Reagents and company used in donor screening
Kit Name Company












Diagnostic Kit for Antibody to
Treponema Pallidum(ELISA)
Beijing BGI-GB
LtdInTec Prodtwo different reagents at the blood centers for the fol-
lowing routine tests: ALT, anti-HIV-1 and −2, anti-HCV,
HBsAg, and syphilis antibody. The two different reagents
used were imported and domestic testing kits. All kits
were approved and licensed by the Chinese State Food
and Drug Administration. All reagents used in donor
screening are varied by blood centers, and are listed in
Table 1. A duplicative test would be performed if a sam-
ple was reactive to one of the rounds of the post-
donation screening tests, using the kit whose result had
been nonreactive. If either test was reactive, the result
was considered to be reactive. The screening “combo”
result, which is the final screening result, was deter-
mined on duplicative testing. A positive combo result
would defer a donor and that involved donated unit
would be discarded. Reactive anti-HIV test results are
required to be confirmed at local public health station
HIV reference laboratories certified by the Ministry of
Health. Staffs from local public-health stations undertake
notification and consultation of donors. ConfirmatoryAI Biological Pharmacy Enterprise Co.,
zon Diagnostics INC.InTec Products, INC.(XIAMEN)BIO-RAD
AI Biological Pharmacy Enterprise Co., Ltd.Zhuhai
stics INC.InTec Products, INC.(XIAMEN)Abbott Molecular
AI Biological Pharmacy Enterprise Co., Ltd.Shanghai Kehua
ING CO., LTDInTec Products, INC.(XIAMEN)bioMérieux Clinical Diagnostics
I Biotech Co., Ltd.Beijing WANTAI Biological Pharmacy Enterprise Co.,
ucts, INC.(XIAMEN)
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not routinely done because of the large number of
donors reactive with anti-HCV, HBsAg, and syphilis
antibodies at screenings as well as the high cost of con-
firmatory testing. There is no national standardized
programme to notify donors about positive test results—
except for HIV—but all donors with positive test results
are informed by telephone and email, or donors learn it
by themselves using the website of the blood center that
is selected by the blood donor before donation. In order
warrant the blood supply in China, we advocate the
disclosure of results of TTIs to blood donors by a well-
defined notification processes to avoid side-effect result-
ing from unguided disclosure. For this analysis, we used
TTI screening test results to calculate TTI prevalence
rates in Whole blood (WB) donations. The prevalence
rate was defined as the number of all screening positives,
excluding ALT, divided by the overall number of WB
donations.Statistical analysis
Statistical analyses were conducted using SPSS 11.5
statistics software. The Chi-square test was applied to
assess the association between the categorical variants.
A P-value of < 0.05 was used as the cut-off level for
significance.Results
Increase in whole blood collection
The change in whole blood collection over the period of
study at the four blood centers is shown in Figure 2.
Compared to 2000, the overall amount of whole blood
collection in 2010 increased by 116% at a rate of 8% per
year, from 374,963 units in 2000 to 808,417 units in
2010. The results of this experiment exhibited theFigure 2 Changes in amount of WB collections among four Chinese bsimilar increasing trend in blood collection at four blood
centers.
Demographic characteristics of the blood donors
A overall of 4,366,283 whole blood donations were col-
lected at the four blood centers between January 1, 2000
and December 31, 2010. Demographic characteristics
associated with all donations within each center are
shown in Table 2. Across all centers, 59.7% of the dona-
tions came from male donors. Approximately half of the
donors were 25 years old or younger. The distribution of
marital status varied by centers, donors with the single
marital status contributed the majority of donations in
Guangzhou, but the distribution presented a majority of
married donors in Yancheng. Not all blood centers col-
lected information on marital status, occupation and
education during the whole eleven years; those data were
therefore excluded from subsequent analyses. Fur-
thermore, there was no effect of education level and
occupation on blood donations among Chinese donors.
Approximately 60% of donations came from first-time
donors and 40% from repeated donors. This trend was
similar in all centers except Yancheng, where 64.7% of
donations came from repeated donors. Of all donations,
53.4% were collected at collection vehicles, but 93.6% of
donations at the Yancheng blood center were collected
at mobile blood collection vehicles and a very small pro-
portion of the overall donations were collected at the
blood center. Overall, the percentage of donations col-
lected at collection vehicles increased dramatically in
recent years (Data not shown) in most centers.
Overall seroprevalence and trend of HIV, HBV, HCV and
syphilis among blood donors
The serologic prevalence status of the 4,366,283 dona-
tions examined with dual-ELISA tests for HIV, HBV,lood centers between 2000 and 2010.
Table 2 Demographic characteristics associated with all donations by center between 2000 and 2010
Liaoning Guangzhou Nanjing Yancheng Overall
Number of donors 774570 2466834 683704 442259 4366283
Male 460052 (59.5) 1510573 (61.2) 379270 (55.5) 258048 (58.3) 2605938 (59.7)
Female 314118 (40.5) 956261 (38.8) 304434 (44.5) 184211 (41.7) 1759955 (40.3)
Age group(years)
18- < 25 355140 (45.9) 1329575 (53.9) 417408 (61.1) 52600 (11.9) 2154555 (49.4)
25- < 35 200156 (25.9) 706815 (28.7) 145686 (21.2) 105191 (23.8) 1157829 (26.5)
35- < 45 157551 (20.3) 325483 (13.2) 87383 (12.8) 142688 (32.2) 713108 (16.3)
45- < 55 59778 (7.8) 104961 (4.2) 33224 (4.9) 141780 (32.1) 340451 (7.8)
Marriage status
Single 388339 (50.2) 1680942 (68.1) *175809 (25.7) 124645 (28.2) 2369735 (54.3)
Married 364818 (47.0) 769425 (31.2) *69534 (10.2) 256732 (58.1) 1460509 (33.4)
Missing 21413 (2.8) 16467 (0.7) 418361 (61.2) 60882 (13.7) 517123 (11.8)
Occupation
Student 358804 (46.3) 510756 (20.7) 148330 (21.7) 33718 (7.6) 1051608 (24.1)
Employed,self-employed, retired 246006 (31.8) 880990 (35.7) 289239 (42.3) 151864 (34.3) 1568099 (35.9)
Other 168676 (21.8) 1065088 (43.2) 18571 (2.7) 249817 (56.5) 1502152 (34.4)
Missing 1084 (0.1) 10000 (0.4) 227564 (33.3) 6860 (1.6) 245508 (5.6)
Education
Below high school 139787 (18.1) 615813 (25.0) *17944 (5.5) 31869 (7.2) 805413 (20.1)
High school 108660 (14.1) 585030 (23.7) *19618 (6.0) 107847 (24.4) 821155 (20.5)
Some college 130250 (16.8) 543266 (22.0) *59781 (18.4) 119207 (27.0) 852504 (21.3)
College degree and above 101880 (13.2) 722725 (29.3) *92389 (28.4) 69295 (15.7) 986289 (24.6)
Other 292909 (37.8) 135353 (41.6) 114040 (25.7) 542302 (13.5)
Donor status
first-time donor 459551 (59.3) 1665940 (67.5) 482211 (70.5) 156010 (35.3) 2763712 (63.3)
Repeat 313935 (40.7) 800894 (32.5) 201493 (29.5) 286249 (64.7) 1602571 (36.7)
Donation site: collection vehicle 426683 (55.1) 1020364 (41.4) 472788 (69.2) 413801 (93.6) 2333636 (53.4)
Data are shown as number (%).
* these data was from 2006–2010.
Li et al. Journal of Translational Medicine 2012, 10:176 Page 5 of 10
http://www.translational-medicine.com/content/10/1/176HCV and syphilis in 2000 through 2010 by the four cen-
ters is presented in Table 3. The overall seroprevalence
rates of HIV, HBV, HCV and syphilis were 0.08%, 0.86%,
0.51% and 0.47%, respectively.
The overall seroprevalence of HBsAg was estimated to
be 0.37%, 0.49%, 0.93% and 1.18% at Yancheng, Nanjing,
Guangzhou and Liaoning, respectively. Each of the
center-specific seroprevalences differed significantly from
the overall mean seroprevalence. Although the preva-
lence in Guangzhou displayed a steady tendency to HBV
prevalence, there was a significant decline over these
eleven years across other three blood centers. With a
similar relative order as for HBsAg mean seroprevalence
and the prevalence trend, all four blood centers demon-
strated statistical differences in the seroprevalence of
HCV except in Guangzhou which was again relatively
stable.
The results from the four blood centers indicated signifi-
cantly distinct HIV prevalence rates as well. The lowestpositivity for HIV (0.02%) appeared at the Guangzhou
blood center, which the rate was four to ten times lower
than those in the other three blood centers. Although
HIV prevalence in Nanjing was also relatively low
(0.08%), it exhibited an upward annual trend. During
2000 and 2001, the prevalence of HIV displayed a rela-
tively high level among the blood donors in Yancheng
and Liaoning, but the data showed a decreasing and rela-
tively lower value in the remaining years of the study.
The prevalence of syphilis also varied among these blood
centers. In Nanjing, the prevalence of syphilis was lowest
(0.36%), with a relatively stable rate. By contrast, the
prevalence in Yancheng was highest (0.70%), with a
stable rate. Guangzhou is one of the largest Chinese
blood centers and revealed a gradual growth trend in
syphilis prevalence. Liaoning indicated a downward
trend of syphilis prevalence over the period.
In addition to the differences by year, the overall sero-
logic positivity rate of these four pathogens also varied
Table 3 Prevalence of serologic markers for TTI by dual ELISA-reactive status at four Chinese blood centers in 2000
through 2010
Blood center 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Overall
HBV
Yancheng 0.47 0.49 0.35 0.23 0.58 0.42 0.37 0.38 0.41 0.27 0.20 0.37}
Nanjing 0.70 0.78 0.57 0.57 0.46 0.47 0.44 0.38 0.40 0.38 0.36 0.49}
Guangzhou 0.85 1.23 1.05 0.95 1.01 1.07 0.92 0.72 0.81 0.88 0.90 0.93}
Liaoning 4.97 3.35 1.58 1.28 0.86 0.56 0.52 0.87 1.11 0.37 0.30 1.18}
Overall 2.09 1.58 1.21 1.07 0.80 0.68 0.66 0.79 0.85 0.55 0.51 0.86
HCV
Yancheng 0.94 0.47 0.44 0.26 0.33 0.34 0.25 0.17 0.15 0.24 0.24 0.29}
Nanjing 0.84 0.45 0.38 0.32 0.33 0.47 0.20 0.20 0.23 0.31 0.32 0.36}
Guangzhou 0.34 0.62 0.55 0.33 0.38 0.23 0.26 0.24 0.46 0.58 0.71 0.47}
Liaoning 2.29 1.85 1.41 1.16 1.04 0.52 0.53 0.63 0.65 1.05 0.72 0.99}
Overall 0.76 0.75 0.70 0.50 0.47 0.33 0.29 0.30 0.42 0.59 0.56 0.51
HIV
Yancheng 0.32 0.36 0.13 0.10 0.33 0.28 0.11 0.16 0.13 0.10 0.11 0.18}
Nanjing 0.02 0.01 0.00 0.00 0.00 0.13 0.10 0.08 0.16 0.12 0.17 0.08
Guangzhou 0.00 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02}
Liaoning 0.69 0.25 0.11 0.20 0.23 0.13 0.15 0.08 0.22 0.31 0.25 0.22}
Overall 0.13 0.06 0.04 0.06 0.09 0.08 0.06 0.06 0.09 0.10 0.10 0.08
Syphilis
Yancheng 0.65 0.75 0.48 0.83 0.88 0.75 0.63 0.60 0.69 0.69 0.70 0.70}
Nanjing 0.30 0.36 0.37 0.40 0.36 0.47 0.35 0.25 0.33 0.30 0.44 0.36}
Guangzhou 0.21 0.29 0.34 0.25 0.30 0.36 0.50 0.53 0.46 0.47 0.66 0.42}
Liaoning 1.00 1.04 1.02 0.71 0.43 0.60 0.57 0.50 0.41 0.38 0.47 0.60}
Overall 0.37 0.44 0.49 0.41 0.38 .046 0.50 0.48 0.45 0.46 0.63 0.47
Data are reported as percentages. } p< 0.01, the p value relates to the overall prevalence.
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occupation and donor status (Table 4). At all four blood
centers, donors under the age of 25 displayed significant
lower positivity for HBV and syphilis. The prevalence of
syphilis was two to four times lower in this group than
in the older age groups. As for HCV, donors above the
age of 46 demonstrated the lowest positivity rate at all
four blood centers; this rate was significantly lower than
that of the other age groups except among donors from
the Guangzhou blood center. As for HIV, no significant
difference was found in the four age groups except
among donors from the Nanjing blood center, where the
oldest age group (46–55 years old) displayed a signifi-
cantly lower positivity rate. A higher positivity rate for
HBV was associated with male at all four blood centers
and male was highly susceptible to other three patho-
gens in the Guangzhou blood center as well. However,
in Yancheng, females were correlated with a higher posi-
tivity rate of HIV, HCV and syphilis. There was a close
correlation between higher positivity rates and lower
education levels, especially for syphilis. The positivity
rate of syphilis among donors who had completed a uni-
versity degree or more educational levels was one-fifthto one-half the rate among those with a high school
degree or less education. Donors who identified them-
selves as students or single marital status displayed a
lower positivity rate than those who were employed or
married. The data reflect that the prevalence rate of
HBV and syphilis was correlated with working status in
all four blood centers. Donations made by first-time
donors had 50-100% higher TTI screening prevalence in
HBsAg, HCV, HIV and syphilis than donations made by
repeated donors except in donations from the Yancheng
blood center where TTI prevalence was almost identical
between the two groups.
Discussion
China is facing critical challenges in blood availability
and safety. Although the volume of blood collected for
transfusion has constantly increased at a rate of 8% per
year in China (Figure 1), the blood supply has not kept
pace with the clinical demand, so China faces consistent
seasonal blood shortage [14]. Despite the successful shift
from paid and employer-organized donations to volun-
tary donations in recent years, the emerging HIV
epidemic, the growing syphilis epidemic and the high
Table 4 Prevalence of serologic markers for TTIs by blood center and demographic characteristics
Yancheng Nanjing Guangzhou Liaoning
Donor characteristics HIV HBV HCV Syphilis HIV HBV HCV Syphilis HIV HBV HCV Syphilis HIV HBV HCV Syphilis
Age (years)
18-25 0.15 0.28 0.35 0.29 0.08 0.44 0.37 0.16 0.00 0.69 0.39 0.19 0.24 1.21 0.98 0.33
26-35 0.18 0.37 0.27 0.58 0.07 0.57 0.38 0.64 0.01 0.94 0.37 0.28 0.21 1.24 0.96 0.74
36-45 0.21 0.43 0.34 0.84 0.08 0.52 0.32 0.66 0.02 1.07 0.48 0.71 0.19 1.27 1.03 0.93
46-55 0.16 0.33 0.24 0.80 0.04 0.55 0.22 0.59 0.01 0.93 0.52 0.75 0.20 1.04 1.00 0.83
Sex
male 0.17 0.42 0.27 0.63 0.08 0.57 0.38 0.34 0.02 1.23 0.51 0.49 0.23 1.29 0.99 0.60
female 0.19 0.30 0.32 0.80 0.07 0.38 0.33 0.37 0.01 0.52 0.28 0.29 0.22 1.03 0.99 0.61
Education
Middle school or less 0.09 0.21 0.24 0.10 0.13 0.60 0.25 0.74 0.02 1.32 0.62 0.69 0.19 0.67 0.65 0.56
High school graduate 0.15 0.67 0.43 0.75 0.13 0.54 0.24 0.83 0.01 0.91 0.46 0.39 0.18 0.67 0.68 0.54
Technician certificate 0.03 0.25 0.21 0.56 0.18 0.47 0.25 0.56 NA NA NA NA 0.20 0.54 0.67 0.37
Associate degree 0.10 0.43 0.35 0.54 0.13 0.31 0.28 0.22 0.003 0.68 0.47 0.27 0.19 0.55 0.64 0.38
Complete university and above 0.09 0.22 0.21 0.34 0.12 0.28 0.31 0.11 0.01 0.82 0.31 0.18 0.19 0.54 0.74 0.26
Marital
Single 0.18 0.37 0.29 0.69 0.13 0.33 0.30 0.19 0.01 0.20 0.17 0.18 0.20 1.04 0.85 0.53
Married 0.18 0.38 0.31 0.71 0.15 0.52 0.22 0.70 0.02 1.28 0.55 0.52 0.25 1.29 1.14 0.68
Occupation
Student 0.17 0.24 0.37 0.16 0.10 0.30 0.33 0.13 0.007 0.87 0.34 0.09 0.26 0.28 1.03 0.21
Working(employed) 0.17 0.37 0.28 0.74 0.12 0.45 0.26 0.45 0.01 0.92 0.43 0.48 0.16 0.48 0.49 0.34
Donor status
First time 0.18 0.37 0.32 0.71 0.09 0.61 0.44 0.42 0.02 1.3 0.50 0.52 0.25 1.46 1.08 0.69
Repeated 0.18 0.37 0.29 0.70 0.05 0.25 0.19 0.23 0.01 0.47 0.33 0.28 0.19 0.67 0.83 0.45
Data are reported as percentages.
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[7-10] are still considered serious blood safety problems
in China. To ensure blood safety, it is critical to monitor
ongoing epidemiological information, not only from
high-risk groups, but also from individuals from the gen-
eral population such as volunteer blood donors. The
donor demographic characteristics of these four blood
centers are quite different from the donor profile of
many Western countries. For example, 60% of donors
were male, half were under age 25, most donors in
Guangzhou were single, and 60% of donations were
from first-time donors (Table 2). To ensure an adequate
blood supply, it is critical to recruit suitable blood
donors. In China, the recruiting strategies to encourage
the current 60% of first-time donors to return for regular
donation are very important to compensate for the
blood shortage.
As the number of HIV cases continues to grow in China,
transfusion-transmissible HIV infection poses an in-
creasing threat to blood safety. By the end of August
2010, there were 361,599 overall reported HIV positives,
including 127,203 AIDS cases and 65,104 recorded
deaths [15]. The Chinese CDC report estimated that forpeople living with HIV(about 650,000) by the end of
2005 in China, about 10.7% of all HIV infections in
China [16] were infected by receiving blood or blood
products (approximately totaling 69,550 cases). The ma-
jority of these cases were infected in late 1980’ and early
1990’ as a result of illegal plasma and whole blood col-
lection practices[17]. The Blood Donation Law published
in 1998 and the closing down of illegal plasma and
whole blood collection operations by the government
have greatly reduced the cases of transfusion transmitted
HIV infections in China after 1998 but there is no offi-
cial published data on the actual cases since 2005. One
study stated that the prevalence rate of HIV infection
was about 0.085% among donors from Zhejiang Prov-
ince, with a growing frequency from 1:600,000 in 1995
to 1:37,500 in 2004[18]. Another meta-analysis indicated
the prevalence and trend of HIV infection among volun-
tary blood donors in China since implementation of the
Blood Donation Law (1998) [19]. This report demon-
strated that an overall 2573 HIV positive cases were
identified among voluntary blood donors between 2000
and 2009 in twenty-nine provinces with a prevalence of
13.33/100 000 and the overall prevalence increasing
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demonstrated a declining trend of HIV prevalence be-
tween 2000 and 2002, and exhibited a mild fluctuation
with a slightly increasing trend in later years (Table 3).
Our results showed varying HIV prevalence rates among
different regions in China, Liaoning (0.22%) and Yan-
cheng (0.18%) displayed four to ten times higher HIV
prevalence among blood donors than Guangzhou
(0.02%) and Nanjing (0.08%).
Since the nationwide HBV vaccination program was
implemented in 1992, the prevalence of HBsAg in the
Chinese population has dropped to 7.2%, but China still
has high HBV prevalence, with approximately 100
million individuals with chronic HBV [8]. Due to pre-
donation HBsAg rapid testing, the prevalence of HBsAg
(0.86%) was much lower in the donor population than
that in the general population. Furthermore, present
data also indicated a significant reduction in HBsAg
contamination in the blood supply over the 11-year
study period despite varying by blood center, such as in
Guangzhou, where there is a demonstrated steady preva-
lent trend (Table 3). Similar decline has been reported in
developed and developing countries [20-23]. The sero-
prevalence of HBV was significantly higher among
donors who were in the higher age groups, male, less
educated, employed, married or first-time donors, as com-
pared to those who were among the lower age groups,
female, more educated, students, single or repeated
donors, respectively (Table 4).
Since the Blood Donation Law was enacted in 1998, the
prevalence of HCV infection has been reduced dramatic-
ally in the general population. Two reasons may contrib-
ute to the significantly higher prevalence in blood
donors than that in the general population before the
Blood Donation Law was enacted. Firstly, before 1998,
due to paid blood donations, blood centers pooled and
centrifuged the blood; they retained the plasma and re-
infused donors with red blood cells from the pool, which
enabled people to sell their plasma more frequently
without developing anemia. Secondly, this may reflect a
significant testing bias and perhaps inaccessibility of
anti-HCV testing among the general population, which
might attract a higher proportion of high-risk persons to
donate blood for the purpose of determining their infec-
tion status. However, the prevalence of HCV infection
slumped dramatically to 1.71% after 1998 [9]. As pre-
sented in Table 3, the prevalence of HCV in China was
significantly lower than it had been before 1998, with
distinguishable differences among various regions. From
2000 to 2006, the prevalence rate showed a significant
decreasing trend. After 2006, the rate started to increase
probably due to a widespread HCV epidemic. Previous
data have shown a high prevalence rate of HBV and
HCV in China, and both viruses share several commoninfectious routes. Both viruses displayed a significant de-
cline among blood donors over the study period. This
decline may imply a decline in HBV and HCV in the
segment of the population recruited to donate; a con-
tinuing increase in the proportion of the population that
has been diagnosed with both viruses; or improved
effectiveness of education and screening processes, re-
sulting in the deferral of persons reporting high-risk
behaviors. As previously discussed, lower prevalence
rates for HBV (0.86%) and HCV (0.51%) were detected
in blood donors than in the general population. This dif-
ference implies that predonation screening and/or self-
selection of blood donors is effective.
China has experienced a dramatic resurgence of syphilis
during the last two decades. Since sexually transmitted
disease (STD) studies in China have reported syphilis
prevalence to be about 10 times higher than HIV preva-
lence in both high-risk and low-risk populations, it is
considered the most pressing public health issues[24].
One study also suggested there was a significant growth
in syphilis serologic markers among first-time donors,
with 0.41%, 0.45%, and 0.57% positivity from 2008 to
2010[13]. Our data indicated the complicated prevalence
of syphilis during the study periods. As indicated in
Table 3, Yancheng and Nanjing displayed a relatively
constant high level of syphilis prevalence over the
period; Guangzhou exhibited a continually growth trend
from 0.21% in 2000 to 0.66% in 2010; and Liaoning
demonstrated a continually decreasing trend from 1.00%
in 2000 to 0.47% in 2010. Higher prevalence rates were
also associated with donors who were older than
25 years, less educated, married, employed, or first-time
donors (Table 4). The overall prevalence rate was high
although the data varied among different regions, time
and characteristic donors. Low education level, high age,
marriage, employment and first-time donation should be
the risk factors for syphilis infection.
Before 1998, TTIs were very common in China due to
contaminated blood collection, particularly in for-profit
plasma collection facilities. To eliminate this risk, the
Chinese government has implemented many strategies,
including banning paid blood donations and recruiting
certain employer-organized and volunteer donations
among low-risk populations [25]. The government has
also implemented more sensitive screen reagents and
different screening strategies. In recent years, the pro-
portion of volunteer donors has rapidly increased, from
5% in 1998 to 71.5% at the end of 2004 and to 99% at
2011. They now constitute the main source of the blood
supply in all major blood banks in China [26].
There are some limitations of this study. Firstly, we did
not do confirmatory tests using widely accepted assays
to perform further testing on these pathogens reactive
and inconclusive donations. The prevalence of these
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tentially affecting our findings about both donor blood-
borne pathogen prevalence and the relative prevalence
of these pathogens between donors and the general
population. Secondly, we have not analyzed these donors
TTIs prevalence in a way to estimate the TTIs residual
risk. Thirdly, not all centers used the same kits during
the study period, and the assays varied among four blood
centers, also weakening the conclusions about the
regional differences in prevalence.
In the present study, we investigated the overall preva-
lence of various TTIs in blood donors giving blood at
four regional Chinese blood centers from 2000 to 2010.
The overall prevalence rates for HIV, HBV, HCV and
syphilis were 0.08%, 0.86%, 0.51% and 0.47%, respect-
ively. The seroprevalence of TTIs appears to be substan-
tially lower among blood donors than in the general
population of China, because of successful screening and
the selection of donors who are at a lower risk for infec-
tion. Although the risk of TTI has been reduced dramat-
ically, the majority of Chinese blood centers currently
still rely on serology tests, with no NAT testing for rou-
tine donor screening. A few studies have demonstrated a
relatively high residual risk compared to developed coun-
tries [27-30]. Fortunately, the government has realized
the importance of NAT testing. In 2011, NAT testing on
HBV, HCV, and HIV was piloted in eleven selected blood
centers. It will be implemented at all provincial-level
blood centers in the next several years. The population
prevalence of TTIs which potentially threaten the safety
of the blood supply, along with rising transfusion
demands for blood, have stimulated an increased
awareness of the importance of strengthening the safety
of the blood supply and blood transfusion in China. We
believe the residual risk of TTIs will be greatly reduced
after NAT implementation.Conclusions
The decreased prevalence rate of HBV and HCV in
Chinese blood donors suggests that the persistent bene-
fit of screening strategies undoubtedly exists. However,
with a higher population prevalence of certain trans-
fusion transmissible blood borne pathogens, and until
widespread implementation of more sensitive donor
screening (such as nucleic acid testing), the residual risk
of many TTIs is most likely higher and to remain so,
than in developed countries. Additional work, particu-
larly in the implementation of NAT testing, needs to be
done to ensure blood safety and availability in China.
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